BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25561458)

  • 1. A novel data-mining approach leveraging social media to monitor consumer opinion of sitagliptin.
    Akay A; Dragomir A; Erlandsson BE
    IEEE J Biomed Health Inform; 2015 Jan; 19(1):389-96. PubMed ID: 25561458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel data-mining platform leveraging social media to monitor outcomes of Januvia.
    Akay A; Dragomir A; Erlandsson BE
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():7484-7. PubMed ID: 24111476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network-based modeling and intelligent data mining of social media for improving care.
    Akay A; Dragomir A; Erlandsson BE
    IEEE J Biomed Health Inform; 2015 Jan; 19(1):210-8. PubMed ID: 25029520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentiment analysis on smoking in social networks.
    Sofean M; Smith M
    Stud Health Technol Inform; 2013; 192():1118. PubMed ID: 23920892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incretin strategy in the treatment of type 2 diabetes mellitus--the DPP-IV inhibitor sitagliptin].
    Perusicová J
    Vnitr Lek; 2007 Oct; 53(10):1109-13. PubMed ID: 18072437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sitagliptin.
    Drucker D; Easley C; Kirkpatrick P
    Nat Rev Drug Discov; 2007 Feb; 6(2):109-10. PubMed ID: 17342863
    [No Abstract]   [Full Text] [Related]  

  • 7. Using social connection information to improve opinion mining: Identifying negative sentiment about HPV vaccines on Twitter.
    Zhou X; Coiera E; Tsafnat G; Arachi D; Ong MS; Dunn AG
    Stud Health Technol Inform; 2015; 216():761-5. PubMed ID: 26262154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sitagliptin].
    Taéron C
    Rev Infirm; 2008 Oct; (144):46-8. PubMed ID: 19009789
    [No Abstract]   [Full Text] [Related]  

  • 9. Sitagliptin/metformin (Janumet) for type 2 diabetes.
    Med Lett Drugs Ther; 2007 Jun; 49(1262):45-7. PubMed ID: 17541377
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sitagliptin. Dipeptidylpeptidase 4 inhibitor for patients with diabetes mellitus type 2].
    Musch A; Heinzl S
    Med Monatsschr Pharm; 2007 Aug; 30(8):282-6; quiz 287-8. PubMed ID: 17879807
    [No Abstract]   [Full Text] [Related]  

  • 11. Sitagliptin in the treatment of type 2 diabetes: a meta-analysis.
    Zhan M; Xu T; Wu F; Tang Y
    J Evid Based Med; 2012 Aug; 5(3):154-65. PubMed ID: 23672222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sitagliptine (Januvia)].
    Duh D; Vandevijver A
    J Pharm Belg; 2008 Mar; 63(1):31-2. PubMed ID: 18479082
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe leucopenia associated with Sitagliptin use.
    Pitocco D; Zaccardi F; Martini F; Scavone G; Musella T; Caputo S; Ghirlanda G
    Diabetes Res Clin Pract; 2011 Feb; 91(2):e30-2. PubMed ID: 21035885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach.
    Xu L; Man CD; Charbonnel B; Meninger G; Davies MJ; Williams-Herman D; Cobelli C; Stein PP
    Diabetes Obes Metab; 2008 Dec; 10(12):1212-20. PubMed ID: 18476982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M; Lam S
    Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sitagliptin in the treatment of type 2 diabetes: insights five years after commercialisation].
    Scheen AJ; Van Gaal LF
    Rev Med Liege; 2013 Oct; 68(10):504-10. PubMed ID: 24298724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three new drugs for type 2 diabetes.
    Drug Ther Bull; 2008 Jul; 46(7):49-52. PubMed ID: 18603639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
    Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sitagliptin: a review.
    Subbarayan S; Kipnes M
    Expert Opin Pharmacother; 2011 Jul; 12(10):1613-22. PubMed ID: 21651449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.